Entia Biosciences, Inc. (ERGO)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Jan 27, 2026

Entia Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Cash & Equivalents
0.080.020.10.040.01
Cash & Short-Term Investments
0.080.020.10.040.01
Cash Growth
215.13%-75.74%169.65%181.98%-21.38%
Accounts Receivable
0.010.010.240.010.06
Other Receivables
---00
Receivables
0.010.010.240.020.07
Inventory
0.070.040.050.140.13
Prepaid Expenses
0.080.060.050.030.03
Total Current Assets
0.230.130.440.230.24
Property, Plant & Equipment
0.020.030.040.060.04
Other Intangible Assets
0.190.230.340.340.18
Other Long-Term Assets
-0.060.05--
Total Assets
0.440.450.870.630.46
Accounts Payable
0.650.60.380.610.43
Accrued Expenses
0.710.370.170.540.22
Short-Term Debt
0.730.280.430.420.14
Current Portion of Long-Term Debt
0.01---0.32
Current Portion of Leases
---00
Other Current Liabilities
---0.010.01
Total Current Liabilities
2.111.240.991.581.11
Long-Term Debt
0.3----
Long-Term Leases
----0
Total Liabilities
2.411.240.991.581.11
Common Stock
0.030.030.020.010.01
Additional Paid-In Capital
12.4912.3110.777.795.12
Retained Earnings
-14.47-13.08-10.82-8.52-5.33
Comprehensive Income & Other
-0.01-0.05-0.09-0.23-0.44
Total Common Equity
-1.97-0.79-0.12-0.95-0.65
Shareholders' Equity
-1.97-0.79-0.12-0.95-0.65
Total Liabilities & Equity
0.440.450.870.630.46
Total Debt
1.050.280.430.420.46
Net Cash (Debt)
-0.97-0.26-0.33-0.39-0.44
Net Cash Per Share
-0.03-0.01-0.04-0.05-0.06
Filing Date Shares Outstanding
33.6628.1115.518.37.44
Total Common Shares Outstanding
28.1528.1115.518.37.44
Working Capital
-1.87-1.11-0.55-1.36-0.86
Book Value Per Share
-0.07-0.03-0.01-0.11-0.09
Tangible Book Value
-2.15-1.02-0.46-1.29-0.83
Tangible Book Value Per Share
-0.08-0.04-0.03-0.16-0.11
Machinery
0.120.120.110.110.06
Leasehold Improvements
0.020.020.020.020.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.